Institutional Repository in Medical Sciences
(IRMS – Nicolae Testemițanu SUMPh)

Preliminary results of the ENERGY study (Ean NEuro-covid ReGistrY) in the Republic of Moldova

Show simple item record

dc.contributor.author Popa, Vera
dc.contributor.author Grosu, Oxana
dc.contributor.author Lisnic, Vitalie
dc.contributor.author Gavriliuc, Mihail
dc.contributor.author Odainic, Olesea
dc.contributor.author Manvelov, Anastasia
dc.contributor.author Cebotari, Ecaterina
dc.date.accessioned 2021-09-27T13:47:23Z
dc.date.available 2021-09-27T13:47:23Z
dc.date.issued 2021
dc.identifier.citation POPA, Vera, GROSU, Oxana, LISNIC, Vitalie, GAVRILIUC, Mihail, ODAINIC, Olesea, et al. Preliminary results of the ENERGY study (Ean NEuro-covid ReGistrY) in the Republic of Moldova. In: The Moldovan Medical Journal. 2021, vol. 64, no 3 (Neuro Congress Issue), p. 22. ISSN 2537-6381.
dc.identifier.issn 2537-6381
dc.identifier.issn 2537-6373
dc.identifier.uri http://moldmedjournal.md/wp-content/uploads/2021/09/Congres-Neuro-2021-Spaltul-11.pdf
dc.identifier.uri http://repository.usmf.md/handle/20.500.12710/18003
dc.description.abstract Background: ENERGY registry developed by the European Academy of Neurology studies neurological manifestations in patients with COVID-19 infections. Diomid Gherman Institute of Neurology and Neurosurgery joined these efforts in December 2020. The aim of the study was to present the Moldovan cohort of patients with COVID-19 infection and neurological manifestations registered in the ENERGY. Material and methods: The registry recorded demographic data, comorbidities, complications, neurological symptoms in confirmed COVID-19 patients. The patients were evaluated at 6 and 12 months by phone. Results: The Moldovan cohort of patients with COVID-19 and neurological manifestations by May 2021 consists of 168 patients (50.6% men and 49.4% women). Most patients (86.9%) had comorbidities, such as arterial hypertension – 83.3%, diabetes mellitus – 23.2 %, cardiovascular – 27.4 %, obesity – 21.4 %. History of neurological diseases with impact on patient’s health was dementia 3.0%, Parkinson’s disease – 1.2%, stroke – 19.0%, multiple sclerosis – 1.2%, neuromuscular disorder – 1.2%, neuropathy – 1.8%. Complications requiring medical intervention were dyspnea – 44.6%, pneumonia – 61.9%, cardiovascular – 7.1%, renal insufficiency – 1.2%, coagulation disorder – 4.2% and mechanical ventilation – 16.1%. New neurological findings in patients with COVID-19 infection were headache (24.4%), vertigo (14.3%), cognitive impairment (35.7%), stupor/coma (22.1%), stroke (62.5%), ataxia (11.4%), spinal cord disorder (7.2%), peripheral neuropathy (5.4%). Mortality rate in the cohort was 22.61%. Conclusions: The Moldovan cohort of patients with neurological manifestations during COVID-19 infections registered in the ENERGY registry presented most frequently at the emergency department with stroke, cognitive impairment and headache. They have many comorbidities, history of neurological diseases, complications during hospital stay and high mortality rate. en_US
dc.language.iso en en_US
dc.publisher The Scientific Medical Association of the Republic of Moldova en_US
dc.relation.ispartof The Moldovan Medical Journal en_US
dc.subject ENERGY en_US
dc.subject EAN en_US
dc.subject Registry en_US
dc.subject NeuroCOVID en_US
dc.title Preliminary results of the ENERGY study (Ean NEuro-covid ReGistrY) in the Republic of Moldova en_US
dc.type Other en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics